Effect of Linagliptin and Voglibose on metabolic profile in patients with Type 2 Diabetes: a randomized, double-blind, placebo-controlled trial

Girish Parthan, Shobhit Bhansali, Anura V. Kurpad, Rama Walia, Kishor Bhat, Anil Bhansali

Open source

DOI
10.1186/s40360-018-0228-z
Published
2018-07-03
Container
BMC Pharmacology and Toxicology
Publisher
Springer Science and Business Media LLC
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1186/s40360-018-0228-z,
  title = {Effect of Linagliptin and Voglibose on metabolic profile in patients with Type 2 Diabetes: a randomized, double-blind, placebo-controlled trial},
  author = {Girish Parthan and Shobhit Bhansali and Anura V. Kurpad and Rama Walia and Kishor Bhat and Anil Bhansali},
  year = {2018},
  journal = {BMC Pharmacology and Toxicology},
  doi = {10.1186/s40360-018-0228-z},
  url = {https://doi.org/10.1186/s40360-018-0228-z}
}

RIS

TY  - JOUR
TI  - Effect of Linagliptin and Voglibose on metabolic profile in patients with Type 2 Diabetes: a randomized, double-blind, placebo-controlled trial
AU  - Girish Parthan
AU  - Shobhit Bhansali
AU  - Anura V. Kurpad
AU  - Rama Walia
AU  - Kishor Bhat
AU  - Anil Bhansali
PY  - 2018
JO  - BMC Pharmacology and Toxicology
DO  - 10.1186/s40360-018-0228-z
UR  - https://doi.org/10.1186/s40360-018-0228-z
ER  - 

APA

Parthan, G., Bhansali, S., Kurpad, A. V., Walia, R., Bhat, K., & Bhansali, A. (2018). Effect of Linagliptin and Voglibose on metabolic profile in patients with Type 2 Diabetes: a randomized, double-blind, placebo-controlled trial. BMC Pharmacology and Toxicology. https://doi.org/10.1186/s40360-018-0228-z

Source records